{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T17:47:06Z","timestamp":1772992026041,"version":"3.50.1"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,19]],"date-time":"2024-10-19T00:00:00Z","timestamp":1729296000000},"content-version":"am","delay-in-days":353,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["T34GM140932"],"award-info":[{"award-number":["T34GM140932"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS086778"],"award-info":[{"award-number":["R01NS086778"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.jns.2023.120828","type":"journal-article","created":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T23:06:27Z","timestamp":1696979187000},"page":"120828","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Lysine 117 on ataxin-3 modulates toxicity in Drosophila models of Spinocerebellar Ataxia Type 3"],"prefix":"10.1016","volume":"454","author":[{"given":"Jessica R.","family":"Blount","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikhil C.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kozeta","family":"Libohova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Autumn L.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Ling","family":"Tsou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alyson","family":"Sujkowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sokol V.","family":"Todi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2023.120828_bb0100","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/ng1194-221","article-title":"CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1","volume":"8","author":"Kawaguchi","year":"1994","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jns.2023.120828_bb0200","first-page":"1247","article-title":"Linkage disequilibrium at the Machado-Joseph disease\/spinal cerebellar ataxia 3 locus: evidence for a common founder effect in French and Portuguese-Brazilian families as well as a second ancestral Portuguese-Azorean mutation","volume":"57","author":"Stevanin","year":"1995","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.jns.2023.120828_bb0205","first-page":"193","article-title":"The gene for spinal cerebellar ataxia 3 (SCA3) is located in a region of approximately 3 cM on chromosome 14q24.3-q32.2","volume":"56","author":"Stevanin","year":"1995","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.jns.2023.120828_bb0085","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2022.974167","article-title":"A survey of protein interactions and posttranslational modifications that influence the polyglutamine diseases","volume":"15","author":"Johnson","year":"2022","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.jns.2023.120828_bb0145","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/nrn.2017.92","article-title":"Polyglutamine spinocerebellar ataxias - from genes to potential treatments","volume":"18","author":"Paulson","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.jns.2023.120828_bb0265","doi-asserted-by":"crossref","first-page":"7425","DOI":"10.1074\/jbc.R800041200","article-title":"Pathogenic mechanisms of a polyglutamine-mediated neurodegenerative disease, spinocerebellar ataxia type 1","volume":"284","author":"Zoghbi","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jns.2023.120828_bb0040","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/978-3-030-38266-7_10","article-title":"Machado-Joseph disease: a stress combating deubiquitylating enzyme changing sides","volume":"1233","author":"Dantuma","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.jns.2023.120828_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2019.104535","article-title":"Differential toxicity of ataxin-3 isoforms in Drosophila models of spinocerebellar Ataxia type 3","volume":"132","author":"Johnson","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jns.2023.120828_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2021.105516","article-title":"Targeting the VCP-binding motif of ataxin-3 improves phenotypes in Drosophila models of spinocerebellar Ataxia type 3","volume":"160","author":"Johnson","year":"2021","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jns.2023.120828_bb0075","doi-asserted-by":"crossref","DOI":"10.3390\/cells11071223","article-title":"Drosophila as a model of unconventional translation in spinocerebellar ataxia type 3","volume":"11","author":"Johnson","year":"2022","journal-title":"Cells."},{"key":"10.1016\/j.jns.2023.120828_bb0080","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.60742","article-title":"Ubiquitin-interacting motifs of ataxin-3 regulate its polyglutamine toxicity through Hsc70-4-dependent aggregation","volume":"9","author":"Johnson","year":"2020","journal-title":"Elife."},{"key":"10.1016\/j.jns.2023.120828_bb0130","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/jnc.14541","article-title":"Machado-Joseph disease\/spinocerebellar ataxia type 3: lessons from disease pathogenesis and clues into therapy","volume":"148","author":"Matos","year":"2019","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jns.2023.120828_bb0010","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1002\/jnr.24684","article-title":"Degron capability of the hydrophobic C-terminus of the polyglutamine disease protein, ataxin-3","volume":"98","author":"Blount","year":"2020","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.jns.2023.120828_bb0020","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms5638","article-title":"Ubiquitin-binding site 2 of ataxin-3 prevents its proteasomal degradation by interacting with Rad23","volume":"5","author":"Blount","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jns.2023.120828_bb0045","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.fob.2013.10.005","article-title":"Enzymatic production of mono-ubiquitinated proteins for structural studies: the example of the Josephin domain of ataxin-3","volume":"3","author":"Faggiano","year":"2013","journal-title":"FEBS Open Bio."},{"key":"10.1016\/j.jns.2023.120828_bb0050","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2015.00002","article-title":"Allosteric regulation of deubiquitylase activity through ubiquitination","volume":"2","author":"Faggiano","year":"2015","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.jns.2023.120828_bb0225","doi-asserted-by":"crossref","first-page":"39303","DOI":"10.1074\/jbc.M110.181610","article-title":"Activity and cellular functions of the deubiquitinating enzyme and Polyglutamine disease protein Ataxin-3 are regulated by ubiquitination at lysine 117","volume":"285","author":"Todi","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jns.2023.120828_bb0230","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/emboj.2008.289","article-title":"Ubiquitination directly enhances activity of the deubiquitinating enzyme ataxin-3","volume":"28","author":"Todi","year":"2009","journal-title":"EMBO J."},{"key":"10.1016\/j.jns.2023.120828_bb0240","doi-asserted-by":"crossref","first-page":"34460","DOI":"10.1074\/jbc.M113.513903","article-title":"Ubiquitination regulates the neuroprotective function of the deubiquitinase ataxin-3 in vivo","volume":"288","author":"Tsou","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jns.2023.120828_bb0255","doi-asserted-by":"crossref","first-page":"26436","DOI":"10.1074\/jbc.M803692200","article-title":"The deubiquitinating enzyme ataxin-3, a polyglutamine disease protein, edits Lys63 linkages in mixed linkage ubiquitin chains","volume":"283","author":"Winborn","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jns.2023.120828_bb0160","doi-asserted-by":"crossref","first-page":"1112688","DOI":"10.3389\/fnins.2022.1112688","article-title":"Ubiquitin-binding site 1 of pathogenic ataxin-3 regulates its toxicity in Drosophila models of spinocerebellar Ataxia Type 3","volume":"16","author":"Prifti","year":"2022","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.jns.2023.120828_bb0055","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1038\/nprot.2007.328","article-title":"Creating transgenic Drosophila by microinjecting the site-specific phiC31 integrase mRNA and a transgene-containing donor plasmid","volume":"2","author":"Fish","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.jns.2023.120828_bb0060","first-page":"1775","article-title":"Construction of transgenic Drosophila by using the site-specific integrase from phage phiC31","volume":"166","author":"Groth","year":"2004","journal-title":"Genetics."},{"key":"10.1016\/j.jns.2023.120828_bb0125","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/ng.101","article-title":"Exploiting position effects and the gypsy retrovirus insulator to engineer precisely expressed transgenes","volume":"40","author":"Markstein","year":"2008","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jns.2023.120828_bb0140","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nmeth1146","article-title":"Vector and parameters for targeted transgenic RNA interference in Drosophila melanogaster","volume":"5","author":"Ni","year":"2008","journal-title":"Nat. Methods"},{"key":"10.1016\/j.jns.2023.120828_bb0025","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0091-679X(08)60936-X","article-title":"Ectopic expression in Drosophila","volume":"44","author":"Brand","year":"1994","journal-title":"Methods Cell Biol."},{"key":"10.1016\/j.jns.2023.120828_bb0030","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1242\/dev.118.2.401","article-title":"Targeted gene expression as a means of altering cell fates and generating dominant phenotypes","volume":"118","author":"Brand","year":"1993","journal-title":"Development."},{"key":"10.1016\/j.jns.2023.120828_bb0210","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1093\/hmg\/ddx039","article-title":"Interaction of the polyglutamine protein ataxin-3 with Rad23 regulates toxicity in Drosophila models of spinocerebellar Ataxia type 3","volume":"26","author":"Sutton","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jns.2023.120828_bb0250","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.nbd.2015.05.010","article-title":"The deubiquitinase ataxin-3 requires Rad23 and DnaJ-1 for its neuroprotective role in Drosophila melanogaster","volume":"82","author":"Tsou","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jns.2023.120828_bb0220","doi-asserted-by":"crossref","first-page":"29348","DOI":"10.1074\/jbc.M704126200","article-title":"Cellular turnover of the polyglutamine disease protein ataxin-3 is regulated by its catalytic activity","volume":"282","author":"Todi","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jns.2023.120828_bb0175","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/gene.10133","article-title":"Conditional expression of UAS-transgenes in the adult eye with a new gene-switch vector system","volume":"34","author":"Roman","year":"2002","journal-title":"Genesis."},{"key":"10.1016\/j.jns.2023.120828_bb0015","doi-asserted-by":"crossref","first-page":"8513","DOI":"10.1038\/s41598-018-26364-x","article-title":"Expression and regulation of deubiquitinase-resistant, unanchored ubiquitin chains in Drosophila","volume":"8","author":"Blount","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jns.2023.120828_bb0005","doi-asserted-by":"crossref","first-page":"7418","DOI":"10.1523\/JNEUROSCI.4540-06.2007","article-title":"Nuclear localization of ataxin-3 is required for the manifestation of symptoms in SCA3: in vivo evidence","volume":"27","author":"Bichelmeier","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jns.2023.120828_bb0185","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/j.1750-3639.1998.tb00193.x","article-title":"An isoform of ataxin-3 accumulates in the nucleus of neuronal cells in affected brain regions of SCA3 patients","volume":"8","author":"Schmidt","year":"1998","journal-title":"Brain Pathol."},{"key":"10.1016\/j.jns.2023.120828_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.103282","article-title":"DNAJB6b-enriched small extracellular vesicles decrease polyglutamine aggregation in in vitro and in vivo models of Huntington disease","volume":"24","author":"Joshi","year":"2021","journal-title":"iScience."},{"key":"10.1016\/j.jns.2023.120828_bb0095","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.2174\/1568026611212220004","article-title":"DNAJ proteins and protein aggregation diseases","volume":"12","author":"Kakkar","year":"2012","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.jns.2023.120828_bb0105","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1126\/science.287.5459.1837","article-title":"Genetic suppression of polyglutamine toxicity in Drosophila","volume":"287","author":"Kazemi-Esfarjani","year":"2000","journal-title":"Science."},{"key":"10.1016\/j.jns.2023.120828_bb0110","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/ncb2200","article-title":"The Machado-Joseph disease deubiquitylase ATX-3 couples longevity and proteostasis","volume":"13","author":"Kuhlbrodt","year":"2011","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.jns.2023.120828_bb0170","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.nbd.2018.04.013","article-title":"Toxicity and aggregation of the polyglutamine disease protein, ataxin-3 is regulated by its binding to VCP\/p97 in Drosophila melanogaster","volume":"116","author":"Ristic","year":"2018","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jns.2023.120828_bb0245","doi-asserted-by":"crossref","first-page":"4385","DOI":"10.1093\/hmg\/ddv174","article-title":"DnaJ-1 and karyopherin alpha3 suppress degeneration in a new Drosophila model of spinocerebellar Ataxia type 6","volume":"24","author":"Tsou","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jns.2023.120828_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev-pathmechdis-012418-012857","article-title":"Polyglutamine repeats in neurodegenerative diseases","volume":"14","author":"Lieberman","year":"2018","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.jns.2023.120828_bb0135","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/jnc.14541","article-title":"Machado-Joseph disease\/spinocerebellar ataxia type 3: lessons from disease pathogenesis and clues into therapy","volume":"148","author":"Matos","year":"2019","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jns.2023.120828_bb0150","doi-asserted-by":"crossref","first-page":"1133271","DOI":"10.3389\/fnmol.2023.1133271","article-title":"Implications of specific lysine residues within ataxin-3 for the molecular pathogenesis of Machado-Joseph disease","volume":"16","author":"Pereira Sena","year":"2023","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.jns.2023.120828_bb0155","doi-asserted-by":"crossref","DOI":"10.1172\/JCI134565","article-title":"Deubiquitinase USP7 contributes to the pathogenicity of spinal and bulbar muscular atrophy","volume":"131","author":"Pluciennik","year":"2021","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jns.2023.120828_bb0195","doi-asserted-by":"crossref","first-page":"1020143","DOI":"10.3389\/fnmol.2022.1020143","article-title":"The role of ubiquitination in spinal and bulbar muscular atrophy","volume":"15","author":"Sengupta","year":"2022","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.jns.2023.120828_bb0120","doi-asserted-by":"crossref","first-page":"436","DOI":"10.2174\/138920312802430608","article-title":"Roles of p97-associated deubiquitinases in protein quality control at the endoplasmic reticulum","volume":"13","author":"Liu","year":"2012","journal-title":"Curr. Protein Pept. Sci."},{"key":"10.1016\/j.jns.2023.120828_bb0260","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1093\/hmg\/ddl164","article-title":"Ataxin-3 binds VCP\/p97 and regulates retrotranslocation of ERAD substrates","volume":"15","author":"Zhong","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jns.2023.120828_bb0180","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.molcel.2011.05.036","article-title":"Ube2w and ataxin-3 coordinately regulate the ubiquitin ligase CHIP","volume":"43","author":"Scaglione","year":"2011","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jns.2023.120828_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108360","article-title":"The deubiquitinating enzyme Ataxin-3 regulates Ciliogenesis and phagocytosis in the retina","volume":"33","author":"Toulis","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.jns.2023.120828_bb0165","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/hmg\/ddp482","article-title":"Proteotoxic stress increases nuclear localization of ataxin-3","volume":"19","author":"Reina","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jns.2023.120828_bb0190","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.bbrc.2007.08.062","article-title":"Inactivation of the mouse Atxn3 (ataxin-3) gene increases protein ubiquitination","volume":"362","author":"Schmitt","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jns.2023.120828_bb0215","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s12017-010-8137-3","article-title":"Mouse ataxin-3 functional knock-out model","volume":"13","author":"Switonski","year":"2011","journal-title":"NeuroMolecular Med."},{"key":"10.1016\/j.jns.2023.120828_bb0035","doi-asserted-by":"crossref","first-page":"4330","DOI":"10.1073\/pnas.0407252102","article-title":"The polyglutamine neurodegenerative protein ataxin 3 regulates aggresome formation","volume":"102","author":"Burnett","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X23002897?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X23002897?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T16:03:46Z","timestamp":1758384226000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X23002897"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":53,"alternative-id":["S0022510X23002897"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2023.120828","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lysine 117 on ataxin-3 modulates toxicity in Drosophila models of Spinocerebellar Ataxia Type 3","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2023.120828","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"120828"}}